Are The Stars Aligned For US Patent Reform This Year?
In a week in which the United States Congress is fighting to avoid a government shutdown over budget disagreements and political posturing is high, technocrats and friends of innovative businesses are working to get passage of a bill to reform US patent law.

On the eve of a meeting of the WHO working group on substandard/spurious/falsely-labelled/falsified/counterfeit medical products, research-based pharmaceutical industry group IFPMA sets out thoughts on building global consensus to address fake medicines.